Sigg C, Plüss H J, Hitzig W H
Schweiz Med Wochenschr. 1980 Jul 8;110(27-28):1056-9.
From 1964-1978 primary non-Hodgkin's lymphoma was diagnosed and treated in 15 children (13 boys and 2 girls). In the 10 patients treated up to 1974, median survival was only 4 months (the longest being 16 months). Since 1974 all such patients have been put on high-dose combined chemotherapy as early as possible. Of 5 children thus treated, 3 have survived for 60, 26 and 11 months respectively and are still alive disease-free. The other two died after 4 1/2 and 5 1/2 months respectively: both had very widespread disease at diagnosis and chemotherapy was delayed by postoperative complications. The 4 most recent tumors have been classified immunologically: 3 were of the B-cell type and exhibited the classic "Burkitt-type" morphology. Two of these patients are alive and well. Although so small a patient material allows no firm conclusions, the authors feel that early intensive chemotherapy may be curative even in this poor-prognosis group of intraabdominal non-Hodgkin's lymphoma.
1964年至1978年间,15名儿童(13名男孩和2名女孩)被诊断并接受了原发性非霍奇金淋巴瘤的治疗。在1974年之前接受治疗的10名患者中,中位生存期仅为4个月(最长为16个月)。自1974年以来,所有此类患者都尽早接受了大剂量联合化疗。在接受如此治疗的5名儿童中,3名分别存活了60个月、26个月和11个月,且仍无病存活。另外两名分别在4个半月和5个半月后死亡:两人在诊断时疾病都非常广泛,化疗因术后并发症而延迟。最近的4例肿瘤进行了免疫分类:3例为B细胞型,呈现典型的“伯基特型”形态。其中两名患者存活且状况良好。尽管如此少的病例资料无法得出确凿结论,但作者认为,即使在这种预后较差的腹腔内非霍奇金淋巴瘤患者群体中,早期强化化疗也可能治愈疾病。